Bioventus Inc. (BVS) Social Stream
BIOVENTUS INC (BVS) Price Targets From Analysts
Use the tables below to see what analysts covering BIOVENTUS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-03-08 | 1 | $23 | $23 | $23 | $4.94 | 365.59% |
| 2021-11-10 | 3 | $25 | $23 | $24 | $4.94 | 385.83% |
| 2022-01-25 | 2 | $25 | $20 | $22.5 | $4.94 | 355.47% |
| 2022-05-11 | 3 | $30 | $18 | $23 | $4.94 | 365.59% |
| 2022-07-14 | 3 | $30 | $11 | $20.666 | $4.94 | 318.34% |
| 2022-08-12 | 4 | $30 | $12 | $18 | $4.94 | 264.37% |
| 2022-09-07 | 4 | $30 | $12 | $16.75 | $4.94 | 239.07% |
| 2022-10-11 | 4 | $30 | $11 | $16.5 | $4.94 | 234.01% |
| 2022-11-09 | 3 | $10 | $5 | $7 | $4.94 | 41.7% |
| 2022-11-30 | 4 | $10 | $2.5 | $5.875 | $4.94 | 18.93% |
| 2023-04-03 | 3 | $6 | $5 | $5.333 | $4.94 | 7.96% |
| 2023-08-10 | 2 | $6 | $6 | $6 | $4.94 | 21.46% |
| 2023-12-07 | 3 | $7 | $6 | $6.5 | $4.94 | 31.58% |
The Trend in the Analyst Price Target
BVS's average price target has moved down $11.5 over the prior 16 months.
BVS reports an average of 169.69% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 3 | 6 | 5 | 5.333 | 1.13 | 371.95% |
| 2023-04-03 | 3 | 6 | 5 | 5.500 | 1.13 | 386.73% |
| 2023-08-10 | 3 | 6 | 6 | 6.000 | 4.57 | 31.29% |
| 2023-08-10 | 2 | 6 | 6 | 6.000 | 4.57 | 31.29% |
| 2023-12-07 | 3 | 7 | 6 | 6.500 | 5.11 | 27.2% |
BVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 0 | 1 | 1 | 3 |
The Trend in the Broker Recommendations
BVS's average broker recommendation rating worsened by 1.33 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BVS as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, BIOVENTUS INC's number of analysts covering the stock is higher than 197.07% of them.
- BIOVENTUS INC's variance in analysts' estimates is lower than -946.16% of all US stocks.
- In terms of how BIOVENTUS INC fares relative to Medical Equipment stocks, note that its average analyst price target is higher than 425.49% of that group.
- BVS has a greater upside potential (average analyst target price relative to current price) than 1425.04% of Medical Equipment stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to BIOVENTUS INC are EMBC, SIEN, and SMTI.
View All Top Stocks by Price Target
What is the outlook for BVS? Use POWR Ratings for clearer insight into price direction.